Logo image of BC8.DE

BECHTLE AG (BC8.DE) Stock Fundamental Analysis

FRA:BC8 - Deutsche Boerse Ag - DE0005158703 - Common Stock - Currency: EUR

37.02  +0.54 (+1.48%)

Fundamental Rating

5

Overall BC8 gets a fundamental rating of 5 out of 10. We evaluated BC8 against 65 industry peers in the IT Services industry. BC8 is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. BC8 is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

BC8 had positive earnings in the past year.
In the past year BC8 had a positive cash flow from operations.
BC8 had positive earnings in each of the past 5 years.
In the past 5 years BC8 always reported a positive cash flow from operatings.
BC8.DE Yearly Net Income VS EBIT VS OCF VS FCFBC8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

BC8 has a Return On Assets of 5.82%. This is in the better half of the industry: BC8 outperforms 66.15% of its industry peers.
The Return On Equity of BC8 (12.84%) is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 9.55%, BC8 is in line with its industry, outperforming 58.46% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BC8 is in line with the industry average of 10.96%.
Industry RankSector Rank
ROA 5.82%
ROE 12.84%
ROIC 9.55%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
BC8.DE Yearly ROA, ROE, ROICBC8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

With a Profit Margin value of 3.89%, BC8 perfoms like the industry average, outperforming 49.23% of the companies in the same industry.
In the last couple of years the Profit Margin of BC8 has grown nicely.
BC8 has a Operating Margin (5.57%) which is comparable to the rest of the industry.
In the last couple of years the Operating Margin of BC8 has grown nicely.
Looking at the Gross Margin, with a value of 18.05%, BC8 is doing worse than 81.54% of the companies in the same industry.
In the last couple of years the Gross Margin of BC8 has grown nicely.
Industry RankSector Rank
OM 5.57%
PM (TTM) 3.89%
GM 18.05%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
BC8.DE Yearly Profit, Operating, Gross MarginsBC8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BC8 is creating value.
BC8 has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, BC8 has about the same amount of shares outstanding.
Compared to 1 year ago, BC8 has an improved debt to assets ratio.
BC8.DE Yearly Shares OutstandingBC8.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BC8.DE Yearly Total Debt VS Total AssetsBC8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

BC8 has an Altman-Z score of 3.85. This indicates that BC8 is financially healthy and has little risk of bankruptcy at the moment.
BC8 has a Altman-Z score of 3.85. This is in the better half of the industry: BC8 outperforms 80.00% of its industry peers.
The Debt to FCF ratio of BC8 is 1.25, which is an excellent value as it means it would take BC8, only 1.25 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 1.25, BC8 belongs to the best of the industry, outperforming 84.62% of the companies in the same industry.
A Debt/Equity ratio of 0.21 indicates that BC8 is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.21, BC8 is doing good in the industry, outperforming 75.38% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.25
Altman-Z 3.85
ROIC/WACC1.44
WACC6.61%
BC8.DE Yearly LT Debt VS Equity VS FCFBC8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BC8 has a Current Ratio of 1.64. This is a normal value and indicates that BC8 is financially healthy and should not expect problems in meeting its short term obligations.
BC8's Current ratio of 1.64 is fine compared to the rest of the industry. BC8 outperforms 73.85% of its industry peers.
A Quick Ratio of 1.41 indicates that BC8 should not have too much problems paying its short term obligations.
The Quick ratio of BC8 (1.41) is better than 69.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.64
Quick Ratio 1.41
BC8.DE Yearly Current Assets VS Current LiabilitesBC8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

3

3. Growth

3.1 Past

BC8 shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -8.02%.
Measured over the past 5 years, BC8 shows a small growth in Earnings Per Share. The EPS has been growing by 7.58% on average per year.
The Revenue has decreased by -1.82% in the past year.
BC8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.25% yearly.
EPS 1Y (TTM)-8.02%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%-6.56%
Revenue 1Y (TTM)-1.82%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%-4.16%

3.2 Future

BC8 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.76% yearly.
Based on estimates for the next years, BC8 will show a small growth in Revenue. The Revenue will grow by 3.74% on average per year.
EPS Next Y2.65%
EPS Next 2Y5.99%
EPS Next 3Y6.76%
EPS Next 5YN/A
Revenue Next Year2.03%
Revenue Next 2Y3.93%
Revenue Next 3Y4.56%
Revenue Next 5Y3.74%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BC8.DE Yearly Revenue VS EstimatesBC8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B 10B
BC8.DE Yearly EPS VS EstimatesBC8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 18.98, BC8 is valued on the expensive side.
BC8's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of BC8 to the average of the S&P500 Index (28.79), we can say BC8 is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 18.49, the valuation of BC8 can be described as rather expensive.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BC8 is on the same level as its industry peers.
The average S&P500 Price/Forward Earnings ratio is at 21.38. BC8 is around the same levels.
Industry RankSector Rank
PE 18.98
Fwd PE 18.49
BC8.DE Price Earnings VS Forward Price EarningsBC8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as BC8.
BC8's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BC8 is cheaper than 64.62% of the companies in the same industry.
Industry RankSector Rank
P/FCF 9.94
EV/EBITDA 9.07
BC8.DE Per share dataBC8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BC8 has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)7.16
PEG (5Y)2.51
EPS Next 2Y5.99%
EPS Next 3Y6.76%

4

5. Dividend

5.1 Amount

BC8 has a Yearly Dividend Yield of 1.92%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 7.47, BC8 has a dividend in line with its industry peers.
Compared to the average S&P500 Dividend Yield of 2.47, BC8 is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.92%

5.2 History

On average, the dividend of BC8 grows each year by 16.00%, which is quite nice.
Dividend Growth(5Y)16%
Div Incr Years4
Div Non Decr Years5
BC8.DE Yearly Dividends per shareBC8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

35.93% of the earnings are spent on dividend by BC8. This is a low number and sustainable payout ratio.
The dividend of BC8 is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP35.93%
EPS Next 2Y5.99%
EPS Next 3Y6.76%
BC8.DE Yearly Income VS Free CF VS DividendBC8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
BC8.DE Dividend Payout.BC8.DE Dividend Payout, showing the Payout Ratio.BC8.DE Dividend Payout.PayoutRetained Earnings

BECHTLE AG

FRA:BC8 (4/25/2025, 7:00:00 PM)

37.02

+0.54 (+1.48%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)03-14 2025-03-14/bmo
Earnings (Next)05-09 2025-05-09
Inst Owners41.11%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap4.66B
Analysts73
Price Target43.12 (16.48%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.92%
Yearly Dividend0.7
Dividend Growth(5Y)16%
DP35.93%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.02%
Min EPS beat(2)-9.76%
Max EPS beat(2)-2.28%
EPS beat(4)0
Avg EPS beat(4)-4.9%
Min EPS beat(4)-9.76%
Max EPS beat(4)-2.28%
EPS beat(8)2
Avg EPS beat(8)-2.1%
EPS beat(12)4
Avg EPS beat(12)-0.87%
EPS beat(16)8
Avg EPS beat(16)1.95%
Revenue beat(2)1
Avg Revenue beat(2)-0.15%
Min Revenue beat(2)-0.86%
Max Revenue beat(2)0.55%
Revenue beat(4)1
Avg Revenue beat(4)-5.58%
Min Revenue beat(4)-16.2%
Max Revenue beat(4)0.55%
Revenue beat(8)3
Avg Revenue beat(8)-0.68%
Revenue beat(12)6
Avg Revenue beat(12)-0.42%
Revenue beat(16)6
Avg Revenue beat(16)-6.42%
PT rev (1m)0.49%
PT rev (3m)-1.34%
EPS NQ rev (1m)-16.73%
EPS NQ rev (3m)-16.73%
EPS NY rev (1m)-0.67%
EPS NY rev (3m)-11.61%
Revenue NQ rev (1m)-4.69%
Revenue NQ rev (3m)-4.69%
Revenue NY rev (1m)-2.51%
Revenue NY rev (3m)-3.76%
Valuation
Industry RankSector Rank
PE 18.98
Fwd PE 18.49
P/S 0.74
P/FCF 9.94
P/OCF 8.36
P/B 2.44
P/tB 5.17
EV/EBITDA 9.07
EPS(TTM)1.95
EY5.27%
EPS(NY)2
Fwd EY5.41%
FCF(TTM)3.73
FCFY10.07%
OCF(TTM)4.43
OCFY11.97%
SpS50.05
BVpS15.17
TBVpS7.16
PEG (NY)7.16
PEG (5Y)2.51
Profitability
Industry RankSector Rank
ROA 5.82%
ROE 12.84%
ROCE 13.47%
ROIC 9.55%
ROICexc 13.16%
ROICexgc 28.2%
OM 5.57%
PM (TTM) 3.89%
GM 18.05%
FCFM 7.45%
ROA(3y)6.7%
ROA(5y)6.98%
ROE(3y)14.8%
ROE(5y)15.62%
ROIC(3y)12.02%
ROIC(5y)11.98%
ROICexc(3y)15.84%
ROICexc(5y)15.71%
ROICexgc(3y)29.63%
ROICexgc(5y)28.23%
ROCE(3y)16.94%
ROCE(5y)16.89%
ROICexcg growth 3Y4.87%
ROICexcg growth 5Y7.72%
ROICexc growth 3Y-3.54%
ROICexc growth 5Y2.28%
OM growth 3Y0.2%
OM growth 5Y6.64%
PM growth 3Y-3.72%
PM growth 5Y4.18%
GM growth 3Y1.35%
GM growth 5Y4.79%
F-Score5
Asset Turnover1.5
Health
Industry RankSector Rank
Debt/Equity 0.21
Debt/FCF 1.25
Debt/EBITDA 0.82
Cap/Depr 63.19%
Cap/Sales 1.41%
Interest Coverage 16.95
Cash Conversion 113.53%
Profit Quality 191.24%
Current Ratio 1.64
Quick Ratio 1.41
Altman-Z 3.85
F-Score5
WACC6.61%
ROIC/WACC1.44
Cap/Depr(3y)72%
Cap/Depr(5y)67.96%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.35%
Profit Quality(3y)113.31%
Profit Quality(5y)113.66%
High Growth Momentum
Growth
EPS 1Y (TTM)-8.02%
EPS 3Y1.89%
EPS 5Y7.58%
EPS Q2Q%-6.56%
EPS Next Y2.65%
EPS Next 2Y5.99%
EPS Next 3Y6.76%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.82%
Revenue growth 3Y5.93%
Revenue growth 5Y3.25%
Sales Q2Q%-4.16%
Revenue Next Year2.03%
Revenue Next 2Y3.93%
Revenue Next 3Y4.56%
Revenue Next 5Y3.74%
EBIT growth 1Y-8.1%
EBIT growth 3Y6.14%
EBIT growth 5Y10.1%
EBIT Next Year41.69%
EBIT Next 3Y17.46%
EBIT Next 5Y10.99%
FCF growth 1Y31.19%
FCF growth 3Y27.55%
FCF growth 5Y27.87%
OCF growth 1Y21.59%
OCF growth 3Y25.19%
OCF growth 5Y24.58%